Search Results

There are 89616 results for: content related to: Radical prostatectomy for clinical stage T3a disease

  1. You have free access to this content
    Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies

    Cancer

    Volume 104, Issue 9, 1 November 2005, Pages: 1911–1917, Mark Garzotto, Yon Park, Solange Mongoue-Tchokote, Jesse Bledsoe, Laura Peters, Bruce H. Blank, Donald Austin, Tomasz M. Beer and Motomi Mori

    Version of Record online : 29 AUG 2005, DOI: 10.1002/cncr.21420

  2. You have free access to this content
    Mutants for photosystem I subunit D of Arabidopsis thaliana: effects on photosynthesis, photosystem I stability and expression of nuclear genes for chloroplast functions

    The Plant Journal

    Volume 37, Issue 6, March 2004, Pages: 839–852, Anna Ihnatowicz, Paolo Pesaresi, Claudio Varotto, Erik Richly, Anja Schneider, Peter Jahns, Francesco Salamini and Dario Leister

    Version of Record online : 23 JAN 2004, DOI: 10.1111/j.1365-313X.2004.02011.x

  3. You have free access to this content
    Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

    Cancer

    Volume 101, Issue 7, 1 October 2004, Pages: 1569–1574, Matthew R. Smith, Judith Manola, Donald S. Kaufman, Daniel George, William K. Oh, Elisabetta Mueller, Susan Slovin, Bruce Spiegelman, Eric Small and Philip W. Kantoff

    Version of Record online : 13 AUG 2004, DOI: 10.1002/cncr.20493

  4. You have free access to this content
    Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations

    Cancer

    Volume 79, Issue 10, 15 May 1997, Pages: 1969–1976, Kazuo Gohji, Masashi Nomi, Shin Egawa, Koichi Morisue, Atsushi Takenaka, Masayuki Okamoto, Makoto Ohori and Akio Fujii

    Version of Record online : 17 JUL 2009, DOI: 10.1002/(SICI)1097-0142(19970515)79:10<1969::AID-CNCR19>3.0.CO;2-T

  5. You have free access to this content
    Watchful waiting or watchful progression?

    Cancer

    Volume 82, Issue 2, 15 January 1998, Pages: 342–348, Duncan B. McLaren, Michael McKenzie, Graeme Duncan and Tom Pickles

    Version of Record online : 31 OCT 2000, DOI: 10.1002/(SICI)1097-0142(19980115)82:2<349::AID-CNCR15>3.0.CO;2-Z

  6. You have free access to this content
    Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1533–1542, Emmanuel S. Antonarakis, Marianna L. Zahurak, Jianqing Lin, Daniel Keizman, Michael A. Carducci and Mario A. Eisenberger

    Version of Record online : 25 AUG 2011, DOI: 10.1002/cncr.26437

  7. You have free access to this content
    Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy

    Cancer

    Volume 97, Issue 4, 15 February 2003, Pages: 1127–1133, Wayne H. Pinover, Eric M. Horwitz, Alexandra L. Hanlon, Robert G. Uzzo and Gerald E. Hanks

    Version of Record online : 3 FEB 2003, DOI: 10.1002/cncr.11166

  8. You have free access to this content
    Critical analysis of prostate-specific antigen doubling time calculation methodology

    Cancer

    Volume 106, Issue 5, 1 March 2006, Pages: 1047–1053, Robert S. Svatek, Michael Shulman, Pankaj K. Choudhary and Elie Benaim

    Version of Record online : 2 FEB 2006, DOI: 10.1002/cncr.21696

  9. You have free access to this content
    The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL

    Cancer

    Volume 104, Issue 5, 1 September 2005, Pages: 993–1003, Carsten Stephan, Greta Stroebel, Marc Heinau, Andre Lenz, Andreas Roemer, Michael Lein, Dietmar Schnorr, Stefan A. Loening and Klaus Jung

    Version of Record online : 8 JUL 2005, DOI: 10.1002/cncr.21267

  10. You have free access to this content
    The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in japan

    Cancer

    Volume 79, Issue 1, 1 January 1997, Pages: 90–98, Shin Egawa, Shigehiro Soh, Makoto Ohori, Toyoaki Uchida, Kazuo Gohji, Akio Fujii, Sadahito Kuwao and Ken Koshiba

    Version of Record online : 27 SEP 2000, DOI: 10.1002/(SICI)1097-0142(19970101)79:1<90::AID-CNCR13>3.0.CO;2-1

  11. You have free access to this content
    Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomy

    Cancer

    Volume 110, Issue 10, 15 November 2007, Pages: 2202–2209, Robert J. Hamilton, William J. Aronson, Joseph C. Presti Jr, Martha K. Terris, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Version of Record online : 17 SEP 2007, DOI: 10.1002/cncr.23012

  12. You have free access to this content
    Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database

    Cancer

    Volume 122, Issue 2, January 15, 2016, Pages: 222–229, Brian T. Hanyok, Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Edwin M. Posadas and Stephen J. Freedland

    Version of Record online : 20 OCT 2015, DOI: 10.1002/cncr.29748

  13. You have free access to this content
    Current role of prostate-specific antigen kinetics in managing patients with prostate cancer

    BJU International

    Volume 97, Issue 3, March 2006, Pages: 451–455, SEAMUS J. TEAHAN and LAURENCE H. KLOTZ

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1464-410X.2006.05958.x

  14. You have free access to this content
    Association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy

    International Journal of Urology

    Volume 19, Issue 8, August 2012, Pages: 741–747, Daniel M Moreira, Leah Gerber, Jean-Alfred Thomas, Lionel L Bañez, Madeline G McKeever and Stephen J Freedland

    Version of Record online : 4 APR 2012, DOI: 10.1111/j.1442-2042.2012.03016.x

  15. You have free access to this content
    Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer

    Cancer

    Volume 107, Issue 9, 1 November 2006, Pages: 2180–2185, Joshua H. Petit, Ming-Hui Chen, Marian Loffredo, Brenda Sussman, Andrew A. Renshaw and Anthony V. D'Amico

    Version of Record online : 28 SEP 2006, DOI: 10.1002/cncr.22243

  16. You have free access to this content
    Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group

    BJU International

    Volume 104, Issue 11, December 2009, Pages: 1604–1609, Anna E. Teeter, Joseph C. Presti Jr, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Version of Record online : 22 JUN 2009, DOI: 10.1111/j.1464-410X.2009.08680.x

  17. You have free access to this content
    Abstracts

    BJU International

    Volume 111, Issue S1, April 2013, Pages: 13–119,

    Version of Record online : 27 MAR 2013, DOI: 10.1111/bju.12069

  18. You have free access to this content
    Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database

    BJU International

    Volume 108, Issue 3, August 2011, Pages: 378–385, Emmanuel S. Antonarakis, Yongmei Chen, Sally I. Elsamanoudi, Stephen A. Brassell, Mario V. Da Rocha, Mario A. Eisenberger and David G. McLeod

    Version of Record online : 23 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09878.x

  19. Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer

    BJU International

    Volume 120, Issue 5B, November 2017, Pages: E80–E86, Lauren E. Howard, Daniel M. Moreira, Amanda De Hoedt, William J. Aronson, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Martha K. Terris and Stephen J. Freedland

    Version of Record online : 30 APR 2017, DOI: 10.1111/bju.13856

  20. You have free access to this content
    Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death

    Cancer

    Volume 109, Issue 1, 1 January 2007, Pages: 41–47, Pino Alcántara, Alexandra Hanlon, Mark K. Buyyounouski, Eric M. Horwitz and Alan Pollack

    Version of Record online : 28 NOV 2006, DOI: 10.1002/cncr.22341